Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 May;10(5):301-16.
doi: 10.1038/nri2761.

Therapeutic antibodies for autoimmunity and inflammation

Andrew C Chan  1 , Paul J Carter
Affiliations
Review

Therapeutic antibodies for autoimmunity and inflammation

Andrew C Chan et al. Nat Rev Immunol. 2010 May.

Abstract

The development of therapeutic antibodies has evolved over the past decade into a mainstay of therapeutic options for patients with autoimmune and inflammatory diseases. Substantial advances in understanding the biology of human diseases have been made and tremendous benefit to patients has been gained with the first generation of therapeutic antibodies. The lessons learnt from these antibodies have provided the foundation for the discovery and development of future therapeutic antibodies. Here we review how key insights obtained from the development of therapeutic antibodies complemented by newer antibody engineering technologies are delivering a second generation of therapeutic antibodies with promise for greater clinical efficacy and safety.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Arthritis Rheum. 2003 Feb;48(2):455-9 - PubMed
    1. Immunol Rev. 2008 Jun;223:20-38 - PubMed
    1. Nature. 1962 Apr 28;194:355-9 - PubMed
    1. Front Biosci. 2008 Jan 01;13:1117-29 - PubMed
    1. J Immunol. 1997 Feb 1;158(3):1438-45 - PubMed

MeSH terms

Substances

LinkOut - more resources